MBX Biosciences

MBX Biosciences(MBX)

CARMEL, IN
Biotechnology

Focus: Hormone Analogues for Rare Endocrine Diseases

MBX Biosciences is a life sciences company focused on Hormone Analogues for Rare Endocrine Diseases.

EndocrinologyRare Diseases
Funding Stage
PUBLIC
Total Funding
$130M
Open Jobs
9

Pipeline & Clinical Trials

MBX 4291
Obesity
Phase 1
Clinical Trials (1)
NCT07142707A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
Phase 1
MBX 2109
Healthy
Phase 1
Clinical Trials (1)
NCT05158335Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of MBX 2109 in Healthy Adult Subjects
Phase 1
Clinical Trials (1)
NCT06036784Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects
Phase 1
Phase 1
Clinical Trials (1)
NCT06496217Safety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function
Phase 1
400 µg of MBX 2109 once-weekly by subcutaneous injection
Hypoparathyroidism
Phase 2
Clinical Trials (1)
NCT06531941Extension Study to Evaluate the Long-Term Safety and Tolerability of MBX 2109 in Patients With Hypoparathyroidism
Phase 2
Clinical Trials (1)
NCT07029412Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI)
Phase 2
Phase 2
Clinical Trials (1)
NCT06465108Safety, Pharmacokinetics and Efficacy of MBX 2109 in Patients With Hypoparathyroidism
Phase 2

Open Jobs (9)

Interview Prep Quick Facts
Portfolio: 7 clinical trials
SEC Filings: 2 available
Open Roles: 9 active jobs

Financials (FY2025)

R&D Spend
$57M101%
Net Income
-$62M
Cash
$49M

Hiring Trend

Stable
9
Open Roles
+4
Added
-2
Filled/Removed

Based on last 4 crawl cycles